Accuray and the University of Wisconsin-Madison Announce Master Research Agreement to Improve Personalized Care for Patients with Cancer
Accuray has entered a 10-year master research agreement with the University of Wisconsin-Madison to advance personalized cancer treatments using its Stellar adaptive radiation therapy platform. The collaboration builds on a decades-long history, dating back to the invention of the TomoTherapy system by UW Professor Thomas Mackie, and will focus on clinical research, education, and the development of adaptive therapies.
Key figures
- Agreement duration
- 10 years
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.